RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Katalin Csiszar to Leukoplakia, Oral

Back to Details
This is a "connection" page, showing publications Katalin Csiszar has written about Leukoplakia, Oral.
Katalin Csiszar
Connection Strength
0.020
Leukoplakia, Oral
  1. Weise JB, Rudolph P, Heiser A, Kruse ML, Hedderich J, Cordes C, Hoffmann M, Brant O, Ambrosch P, Csiszar K, G?r?gh T. LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer. Eur J Cancer. 2008 Jun; 44(9):1323-31.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support